WaferGen Biosystems Launches SmartChip TE - A Novel Target Enrichment Solution for Next-Gen Sequencing (NGS) Aimed at Clinical Applications
5/9/2013 10:00:37 AM
More...
|
WaferGen Biosystems Partners With Salk Institute for Biological Studies to Establish a Nano-qPCR Core Lab
3/11/2013 11:33:01 AM
More...
|
WaferGen Biosystems and QIAGEN KK Sign Agreement for Co-Marketing in Japan
2/19/2013 11:15:10 AM
More...
|
WaferGen Biosystems's MyDesign Open Platform Facilitates Rapid Development of a Proprietary Prostate Cancer Diagnostic Panel in the Lab of Dr. Arul Chinnaiyan at the University of Michigan Cancer Center
1/28/2013 10:30:43 AM
More...
|
WaferGen Biosystems Announces Highly Successful Initial Customer Testing of Its Previously Unannounced Novel Target Enrichment Technology for Next-Gen Sequencing (NGS)
1/8/2013 10:15:40 AM
More...
|
WaferGen Biosystems Obtains Exclusive License for RNA QC IP From Rutgers University and Establishes a Strategic Collaboration with RUCDR Infinite Biologics
11/9/2012 12:55:25 PM
More...
|
WaferGen Biosystems Awarded 1 Million Euro Grant by the Luxembourg Government to expand its European Operations
9/19/2012 10:10:15 AM
More...
|
WaferGen Biosystems Launches MyDesign - Setting a New Standard in Flexibility with an Open Format High-Throughput qPCR Platform
7/11/2012 9:55:14 AM
More...
|
WaferGen Biosystems Announces Open Format qPCR Platform and Strategic Realignment
4/16/2012 10:38:36 AM
More...
|
WaferGen Biosystems Appoints Ivan Trifunovich President, CEO, and Director
3/12/2012 8:07:39 AM
More...
|
|